Bingke Zhao Selected Research

Neoplasms (Cancer)

1/2024	Nanoparticle/Engineered Bacteria Based Triple-Strategy Delivery System for Enhanced Hepatocellular Carcinoma Cancer Therapy.
1/2023	Engineered bacteria combined with doxorubicin nanoparticles suppress angiogenesis and metastasis in murine melanoma models.
9/2022	Enzyme-loaded glycogen nanoparticles with tumor-targeting Activatable host-guest supramolecule for augmented chemodynamic therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bingke Zhao Research Topics

Disease

3	Neoplasms (Cancer) 01/2024 - 09/2022
1	Hepatocellular Carcinoma (Hepatoma) 01/2024
1	Melanoma (Melanoma, Malignant) 01/2023
1	Neoplasm Metastasis (Metastasis) 01/2023
1	Starvation 09/2022

Drug/Important Bio-Agent (IBA)

2	EnzymesIBA 01/2023 - 09/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023
1	GlycogenIBA 09/2022
1	hydroxide ionIBA 09/2022
1	Glucose (Dextrose)FDA LinkGeneric 09/2022
1	Glucose OxidaseIBA 09/2022
1	gluconic acid (gluconate)FDA LinkGeneric 09/2022

Therapy/Procedure

3	Therapeutics 01/2024 - 09/2022
2	Drug Therapy (Chemotherapy) 01/2024 - 01/2023
1	Intravenous Injections 01/2024
1	Biological Therapy 01/2023